Urokinase-type plasminogen activator is required for the generation of a type 1 immune response to pulmonary Cryptococcus neoformans infection

被引:47
|
作者
Gyetko, MR
Sud, S
Chen, GH
Fuller, JA
Chensue, SW
Toews, GB
机构
[1] Ann Arbor Vet Affairs Med Ctr, Pulm & Crit Care Med Div, Dept Internal Med, Ann Arbor, MI 48105 USA
[2] Ann Arbor Vet Affairs Med Ctr, Pulm & Crit Care Med Div, Dept Pathol, Ann Arbor, MI 48105 USA
[3] Univ Michigan, Med Ctr, Ann Arbor, MI 48109 USA
来源
JOURNAL OF IMMUNOLOGY | 2002年 / 168卷 / 02期
关键词
D O I
10.4049/jimmunol.168.2.801
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Urokinase-type plasminogen activator (uPA)(-/-) mice cannot mount protective host defenses during infection with the opportunistic yeast Cryptococcus neoformaus (52D). Because effective host defense against C. neoformans requires specific immune responses and the generation of type 1 (T1) cytokines, we determined how the absence of uPA impacts these processes. Wild-type (WT) and uPA(-/-) mice were inoculated with C. neoformans. Macrophage antifungal activity was assessed histologically, T lymphocyte responses in vivo and proliferation in vitro were quantified, and cytokine concentrations were determined by ELISA. uPA(-/-) macrophages have impaired antimicrobial activity. Regional lymph nodes of infected uPA(-/-) mice contained fewer cells than WT, suggesting impaired T cell proliferation in response to the pathogen in vivo. In vitro, uPA(-/-) T lymphocytes had impaired proliferative responses to C. neoformans rechallenge compared with WT. Infected WT mice generated T1 cytokines in the lung, characterized by high levels of IFN-gamma and IL-12. uPA(-/-) mice had decreased levels of IFN-gamma and IL-12, and increased IL-5, a type 2 cytokine. In the absence of uPA, the cytokine profile of regional lymph nodes shifted from a T1 pattern characterized by IFN-gamma and IL-2 to a weak, nonpolarized response. We conclude that in the absence of uPA, lymphocyte proliferative responses are diminished, and mice fail to generate protective T1 cytokines, resulting in impaired antimicrobial activity. This study provides novel evidence that uPA is a critical modulator of immune responses and of immune cell effector functions in vivo.
引用
收藏
页码:801 / 809
页数:9
相关论文
共 50 条
  • [41] Role of urokinase-type plasminogen activator in local immunotherapy
    Takeda, T
    Ito, Y
    Wakasugi, E
    Kobayashi, T
    Monden, M
    ONCOLOGY REPORTS, 1998, 5 (02) : 329 - 333
  • [42] The urokinase-type plasminogen activator and its receptor in cancer
    Rosenberg, S
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34, 1999, 34 : 121 - 128
  • [43] THE MURINE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR GENE
    DEGEN, SJF
    HECKEL, JL
    REICH, E
    DEGEN, JL
    BIOCHEMISTRY, 1987, 26 (25) : 8270 - 8279
  • [44] Inhibitors of the protease domain of urokinase-type plasminogen activator
    Rockway, TW
    Nienaber, V
    Giranda, VL
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (28) : 2541 - 2558
  • [45] Association of urokinase-type plasminogen activator with asthma and atopy
    Begin, Philippe
    Tremblay, Karine
    Daley, Denise
    Lemire, Mathieu
    Claveau, Sebastien
    Salesse, Charleen
    Kacel, Sabine
    Montpetit, Alexandre
    Becker, Allan
    Chan-Yeung, Moira
    Kozyrskyj, Anita L.
    Hudson, Thomas J.
    Laprise, Catherine
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (11) : 1109 - 1116
  • [46] Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients
    Chung, HC
    Rha, SY
    Park, JO
    Yoo, NC
    Kim, JH
    Roh, JK
    Min, JS
    Lee, KS
    Kim, BS
    Kim, JJ
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 49 (01) : 41 - 50
  • [47] Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients
    Hyun Cheol Chung
    Sun Young Rha
    Joon Oh Park
    Nae Choon Yoo
    Joo Hang Kim
    Jae Kyung Roh
    Jin Sik Min
    Kyong Sik Lee
    Byung Soo Kim
    Jin Ju Kim
    Breast Cancer Research and Treatment, 1998, 49 : 41 - 50
  • [48] Differential effects of acute and chronic wound fluids on urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and tissue-type plasminogen activator in cultured human keratinocytes and fibroblasts
    Weckroth, M
    Vaheri, A
    Myöhänen, H
    Tukiainen, E
    Sirén, V
    WOUND REPAIR AND REGENERATION, 2001, 9 (04) : 314 - 322
  • [49] Nipple Aspirate Fluid Expression of Urokinase-Type Plasminogen Activator, Plasminogen Activator Inhibitor-1, and Urokinase-Type Plasminogen Activator Receptor Predicts Breast Cancer Diagnosis and Advanced Disease
    Wenyi Qin
    Weizhu Zhu
    Colette Wagner-Mann
    Edward R. Sauter
    Annals of Surgical Oncology, 2003, 10 : 948 - 953
  • [50] Nipple aspirate fluid expression of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor predicts breast cancer diagnosis and advanced disease
    Qin, WY
    Zhu, WZ
    Wagner-Mann, C
    Sauter, ER
    ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (08) : 948 - 953